Neuvivo grabs funding
Neuvivo, a late-clinical stage biopharmaceutical company, has secured an undisclosed amount of funding.
Neuvivo, a late-clinical stage biopharmaceutical company, has secured an undisclosed amount of funding.
Copyright PEI Media
Not for publication, email or dissemination